Addus HomeCare (NASDAQ:ADUS) Releases Quarterly Earnings Results, Beats Estimates By $0.10 EPS

Addus HomeCare (NASDAQ:ADUS) issued its quarterly earnings results on Monday. The company reported $1.62 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.52 by $0.10, FiscalAI reports. Addus HomeCare had a return on equity of 9.84% and a net margin of 6.74%.The company had revenue of $363.50 million for the quarter, compared to analysts’ expectations of $366.41 million.

Addus HomeCare Price Performance

Shares of NASDAQ ADUS traded up $0.56 during mid-day trading on Monday, reaching $100.12. The company had a trading volume of 387,357 shares, compared to its average volume of 238,113. The company has a current ratio of 1.80, a quick ratio of 1.80 and a debt-to-equity ratio of 0.11. The stock has a market cap of $1.87 billion, a PE ratio of 19.22, a P/E/G ratio of 1.37 and a beta of 0.92. The company has a 50-day moving average price of $98.77 and a two-hundred day moving average price of $107.81. Addus HomeCare has a 1-year low of $90.89 and a 1-year high of $124.43.

Analyst Ratings Changes

Several equities analysts have recently issued reports on ADUS shares. KeyCorp reiterated an “overweight” rating on shares of Addus HomeCare in a research report on Wednesday, February 25th. Stephens lowered their price target on Addus HomeCare from $140.00 to $135.00 and set an “overweight” rating on the stock in a research report on Wednesday, February 25th. Weiss Ratings reiterated a “hold (c+)” rating on shares of Addus HomeCare in a research report on Wednesday, January 21st. Wall Street Zen cut Addus HomeCare from a “strong-buy” rating to a “buy” rating in a research report on Saturday, March 21st. Finally, Truist Financial set a $135.00 price target on Addus HomeCare and gave the company a “buy” rating in a research report on Wednesday, January 7th. One equities research analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating, two have assigned a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, Addus HomeCare presently has a consensus rating of “Moderate Buy” and an average price target of $133.22.

Insiders Place Their Bets

In related news, EVP Darby Anderson sold 733 shares of Addus HomeCare stock in a transaction on Tuesday, February 24th. The stock was sold at an average price of $106.98, for a total value of $78,416.34. Following the transaction, the executive vice president directly owned 46,642 shares in the company, valued at $4,989,761.16. The trade was a 1.55% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, EVP Brian Poff sold 2,041 shares of Addus HomeCare stock in a transaction on Tuesday, February 24th. The stock was sold at an average price of $106.98, for a total value of $218,346.18. Following the completion of the transaction, the executive vice president owned 64,512 shares in the company, valued at $6,901,493.76. The trade was a 3.07% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Over the last ninety days, insiders sold 16,788 shares of company stock worth $1,785,633. Corporate insiders own 4.50% of the company’s stock.

Hedge Funds Weigh In On Addus HomeCare

A number of hedge funds have recently modified their holdings of ADUS. Freestone Grove Partners LP grew its holdings in shares of Addus HomeCare by 5,035.2% in the 4th quarter. Freestone Grove Partners LP now owns 137,932 shares of the company’s stock worth $14,813,000 after acquiring an additional 135,246 shares during the last quarter. Empowered Funds LLC grew its holdings in shares of Addus HomeCare by 186.1% during the fourth quarter. Empowered Funds LLC now owns 70,927 shares of the company’s stock valued at $7,617,000 after buying an additional 46,137 shares in the last quarter. Adage Capital Partners GP L.L.C. purchased a new position in shares of Addus HomeCare during the second quarter valued at $4,838,000. Punch & Associates Investment Management Inc. raised its position in Addus HomeCare by 29.1% during the third quarter. Punch & Associates Investment Management Inc. now owns 143,655 shares of the company’s stock valued at $16,950,000 after buying an additional 32,355 shares during the period. Finally, Raymond James Financial Inc. raised its position in Addus HomeCare by 5,969.5% during the third quarter. Raymond James Financial Inc. now owns 32,047 shares of the company’s stock valued at $3,781,000 after buying an additional 31,519 shares during the period. 95.35% of the stock is currently owned by institutional investors and hedge funds.

Addus HomeCare Company Profile

Addus HomeCare (NASDAQ: ADUS) is a leading provider of home and community-based care services for elderly, disabled, and medically complex individuals across the United States. Through a network of company-owned and franchise locations, the company delivers a broad spectrum of non-medical personal care and licensed home health services designed to support clients’ independence and quality of life.

The company’s core offerings include personal care assistance—covering daily living activities, medication reminders, and light housekeeping—and skilled home health services delivered under the supervision of registered nurses and licensed therapists.